Atsena Therapeutics rakes in $55m Series A

Atsena Therapeutics, a clinical-stage gene therapy company, has secured $55 million in Series A financing.

Atsena Therapeutics, a clinical-stage gene therapy company, has secured $55 million in Series A financing. Sofinnova Investments led the round.

Source: Press Release